public interest | Khurana and Khurana

Right to Information Act, 2005 (RTI) And Judicial Activism: Accountability and Independence Go Hand in Hand

29th March, 2022 - 12:13 pm Categories: Intellectual Property

Right to Information Act, 2005 (RTI) was introduced as a fundamental right to make it mandatory for the governmental bodies to disclose information. Under this act, a person can make a request to the governmental bodies to disclose certain information and the concerned authorities have to respond with the necessary data unless they have some … Continue reading Right to Information Act, 2005 (RTI) And Judicial Activism: Accountability and Independence Go Hand in Hand

All About Section 31 D of Copyright Act, 1957

9th October, 2018 - 5:26 am Categories: Copyright

0 Comments

The 2012 amendment in Copyright Act has introduced various provisions, one of them being section 31 D. This section is concerned with the broadcasting or performance of a literary or musical and sound recording, which has already been published. Clause 1 of Section 31D states: “Any broadcasting organization desirous of communicating to the public by … Continue reading All About Section 31 D of Copyright Act, 1957

CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

17th December, 2014 - 8:25 am Categories: India IP Litigation IP Practice in India News & Updates Patent Litigation Patents pharma Pharma/Biotech Patent Litigations

0 Comments

As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s plea here. Background: Cipla, previously approached the Department of Industrial Policy and Promotion (DIPP) to … Continue reading CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

1st November, 2014 - 5:27 pm Categories: India IP Litigation IP Practice in India News & Updates Patent Litigation Patents pharma Pharma/Biotech Patent Litigations

0 Comments

It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy & Promotion) seeking revocation of five patents of Novartis on indacaterol, a respiratory drug for the treatment of chronic obstructive pulmonary disease (COPD) and marketed as Onbrez by Novartis. The central government, under section 66 … Continue reading Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

Tag: public interest

Right to Information Act, 2005 (RTI) And Judicial Activism: Accountability and Independence Go Hand in Hand

All About Section 31 D of Copyright Act, 1957

CIPLA’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

Cipla Files Representation with Govt. Seeking Revocation of Novartis’ Patents

Categories

Archives